Related Experiment Video
Updated: Mar 28, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
[Biologic treatments for hereditary diseases]
Biological therapies show promise for treating hereditary diseases, including monogenic disorders, by targeting causative genes. Further research is crucial to confirm the safety and effectiveness of these innovative treatments before human clinical trials.
Area of Science:
- Genetics and Molecular Biology
- Biotechnology
- Pediatric Medicine
Background:
- Hereditary diseases, particularly monogenic disorders, are a leading cause of childhood malformations and disabilities.
- Current treatments for most hereditary diseases are limited to symptom management.
- Emerging biological techniques offer potential therapeutic avenues by targeting specific genes.
Purpose of the Study:
- To review the current status and potential of biological techniques for treating hereditary diseases.
- To highlight the need for further validation of these therapies before clinical application.
Main Methods:
- Review of existing literature on biological therapies for hereditary diseases.
- Analysis of techniques including transgenic approaches, RNA interference, and genome editing.
- Examination of studies conducted primarily in animal models.
Main Results:
- Biological techniques like transgenic methods, RNA interference, and genome editing have demonstrated success in preclinical models for hereditary diseases.
- These advanced therapies offer a potential alternative to symptomatic treatments.
Conclusions:
- While promising, biological therapies for hereditary diseases require rigorous validation of efficacy and safety in animal models.
- Further development of mechanism-based therapeutic approaches is essential prior to human clinical trials.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
Related Concept Videos
Gene Therapy
Gene Therapy
Pharmacogenomics: Identification of New Drug Targets
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Drug Products: Biologics, Biosimilars and Interchangeables